Literature DB >> 16694920

COMPLEMENT ACTIVITY IN PNEUMONIA.

D D Rutstein1, W H Walker.   

Abstract

Year:  1942        PMID: 16694920      PMCID: PMC435148          DOI: 10.1172/JCI101308

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  IMMUNOLOGICAL STUDIES ON PATIENTS WITH PNEUMOCOCCIC PNEUMONIA TREATED WITH SULFAPYRIDINE.

Authors:  M Finland; W C Spring; F C Lowell
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

2.  ANTIBODY FORMATION IN CASES OF LOBAR PNEUMONIA TREATED WITH SULFAPYRIDINE.

Authors:  Y Kneeland; B Mulliken
Journal:  J Clin Invest       Date:  1940-03       Impact factor: 14.808

3.  ANTIBODY FORMATION IN CASES OF LOBAR PNEUMONIA TREATED WITH SULFATHIAZOLE.

Authors:  Y Kneeland; B Mulliken
Journal:  J Clin Invest       Date:  1940-09       Impact factor: 14.808

4.  A QUANTITATIVE, ABSOLUTE METHOD FOR THE ESTIMATION OF COMPLEMENT (ALEXIN).

Authors:  M Heidelberger
Journal:  Science       Date:  1940-12-06       Impact factor: 47.728

  4 in total
  12 in total

1.  Classical and alternative complement pathway activation by pneumococci.

Authors:  C G Stephens; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  COMPLEMENT IN INFECTIOUS DISEASE IN MAN.

Authors:  E E Ecker; S Seifter; T F Dozois; L Barr
Journal:  J Clin Invest       Date:  1946-11       Impact factor: 14.808

3.  THE DETERIORATION OF COMPLEMENT ACTIVITY IN NORMAL HUMAN SERUM.

Authors:  A W Pohl; D D Rutstein
Journal:  J Clin Invest       Date:  1944-03       Impact factor: 14.808

4.  SEROLOGICAL STUDIES IN RHEUMATIC FEVER. II. SERUM COMPLEMENT IN THE RHEUMATIC STATE.

Authors:  E E Fischel; R H Pauli; J Lesh
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

5.  COMPLEMENT AND ITS COMPONENT FRACTIONS IN CEREBROSPINAL FLUID IN INFLAMMATORY CEREBROSPINAL DISEASES.

Authors:  S Spicer; E Appelbaum; D D Rutstein
Journal:  J Clin Invest       Date:  1949-03       Impact factor: 14.808

6.  THE COMPLEMENT CONTENT OF HUMAN SERA WITH ESPECIAL REFERENCE TO MALARIA.

Authors:  A D Dulaney; J B Priest; M L Almeda; B Parker
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

7.  Serum complement in acute nephritis.

Authors:  R READER
Journal:  Br J Exp Pathol       Date:  1948-06

8.  Alterations in serum opsonic activity and complement levels in pneumococcal disease.

Authors:  G S Giebink; T H Dee; Y Kim; P G Quie
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

9.  Experimental study of diphtheritic polyneuritis in the rabbit and guinea pig. I. Immunologic and histopathologic observations.

Authors:  B H WAKSMAN; R D ADAMS; H C MANSMANN
Journal:  J Exp Med       Date:  1957-06-01       Impact factor: 14.307

10.  Reduction of circulating granulocytes induced by type 1 pneumococcal cell walls in New Zealand white rabbits.

Authors:  S E Goldblum; W P Reed; L L Barton
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.